Market News How it works Learn FAQ
| RCT 0.1382 81.60% | NU 11.97 -21.04% | TGL 0.2617 18.15% | EWZ 32.715 -23.19% | SRTM 0.3394 -21.12% | BBD 2.835 -30.34% | SHFS 0.0989 -25.30% | GCDT 0.1322 -24.93% | ITUB 7.368 -23.81% | NWGL 0.0817 -0.37% | CLRO 4.67 43.69% | XP 14.8623 -51.13% | AZTR 1.265 76.92% | RBNE 0.1664 -12.42% | PBR 21.535 -17.68% | SGRY 23.055 46.38% | SOXL 85.96 2.87% | TSLL 10.8899 11.58% | SPCX 147.535 0.03% | VALE 12.0045 -3.19% | SPRC 1.4499 33.02% | NVD 4.04 -3.58% | CRWV 54.96 1.34% | JBLU 2.2085 -15.87% | SOXS 51.01 -2.76% | INTC 87.29 0.38% | GPUS 0.1679 -0.59% | NVDA 215 1.92% | TSLA 394.1 5.88% | IREN 24.64 -1.06% | ABEV 2.7991 -15.18% | TQQQ 67.83 2.32% | RENT 2.9899 30.00% | NOK 8.46 3.93% | INTR 4.415 -38.60% | PBR-A 18.92 -19.59% | XTND 2.8083 58.66% | SQQQ 38.76 -2.32% | BITO 10.6402 -1.75% | LUCD 0.5437 32.29% | SPDN 8.495 -0.53% | VBIO 0.8098 -13.85% | SBS 4.765 -25.55% | XXII 0.0999 -49.47% | SID 0.9233 -21.75% | STNE 7.96 -30.66% | KORU 10.6 0.19% | WFF 0.0765 -4.38% | RWM 14.4501 -0.69% | TSLG 5.45 11.91%
POPredictive Oncology Inc. logo

Predictive Oncology Inc. (POAI)

NASDAQ Capital Market · Currency in USD
$4.91 ▲ +0.29 (+6.28%)
As of Apr 21, 3:59 PM ET. Market open.

Summary

Previous Close
$4.62
Open
$4.49
Day's Range
$4.21 – $4.98
52 Week Range
$1.21 – $45.90
Volume
19,088
Avg. Volume
107,042
Market Cap
$3.57M
Beta (5Y Monthly)
1.35
PE Ratio (TTM)
--
EPS (TTM)
-$12.00
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Predictive Oncology Inc.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
23
CEO
Raymond F. Vennare

Predictive Oncology Inc. (POAI), an organization driven by expertise and data, is dedicated to pioneering individualized cancer treatments through the application of artificial intelligence, primarily within the United States. The company conducts its operations across four distinct divisions: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics division offers extensive clinical diagnostic services, including tumor drug response assessments and genomic profiling, alongside contract research focused on patient-centered drug discovery.

Earnings

DateEst.Actual
Nov 14, 2025-$1.35-$4.52Miss
Aug 14, 2025-$1.35-$3.30Miss
May 15, 2025-$1.35-$4.80Miss
Apr 1, 2025-$0.25-$0.25Beat
Nov 13, 2024-$4.80-$5.40Miss
Aug 14, 2024–-$10.19

Analyst view

Rating: Hold
Buy 0% · Hold 100% · Sell 0%

Get free alerts on POAI and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.